Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

CHINA: Nearly 120,000 New Cases of TB in China Every Year




 

China Daily (Africa) (04.19.13)

Accounting for 25 percent of global multidrug-resistant TB (MDR TB), China currently has nearly 120,000 new cases on the mainland each year, according to the Chinese Center for Disease Control and Prevention. MDR TB is defined as TB that is resistant to first-line drugs isoniazid and rifampicin and requires much more expensive treatment compared with common TB. According to Chen Mingting, deputy director of the National Center for Tuberculosis of China CDC, MDR TB causes substantial economic and human resource losses. Citing previous studies conducted by China CDC, without effective intervention, the number of MDR TB cases in China is expected to reach 710,000 by the year 2020. Currently, the government provides free treatment for common TB but not for MDR TB, which is much more costly to treat. According to the World Health Organization, nearly 4 percent of newly-infected individuals are initially resistant to multiple drugs, meaning that MDR TB is being transmitted directly from person to person. China’s State Food and Drug Administration has approved the new drug Sirturo, manufactured by Xi’an Janssen Pharmaceutical Ltd., to provide additional drug choices for treating MDR TB.



 


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in April 22, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.